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One Sentence Summary: A chiral Brønsted acid and an iridium photocatalyst enable catalytic 
enantioselective Minisci-type addition of prochiral radicals to pyridines and quinolines. 
Abstract: Basic heteroarenes are a ubiquitous feature of pharmaceuticals and bioactive 
molecules, and Minisci-type additions of radical nucleophiles are a leading method for their 
elaboration. Despite many Minisci-type protocols that result in the formation of stereocenters, 
exerting control over the absolute stereochemistry at these centers remains an unmet challenge. 
We report a process for addition of prochiral radicals, generated from amino acid derivatives, to 
pyridines and quinolines with excellent control of both enantioselectivity and regioselectivity. 
An enantiopure chiral Brønsted acid catalyst serves both to activate the substrate and induce 
asymmetry, while an iridium photocatalyst mediates the required electron transfer processes. We 
anticipate that this method will expedite access to enantioenriched small-molecule building 
blocks bearing versatile basic heterocycles.   
Main Text:  
Heteroarenes with basic nitrogen centers, of which pyridines and quinolines are the most 
common classes, are ubiquitous in pharmaceuticals, agrochemicals and small molecules of 
medicinal interest (1, 2). The nitrogen’s basicity precludes traditional electrophilic aromatic 
substitution pathways, necessitating alternative strategies for elaboration. One widely used 
protocol is the addition of free radicals to protonated heterocycles, pioneered by Minisci in the 
1960s and 1970s and often referred to as ‘Minisci-type’ chemistry (3-6). Recent renewed interest 
has led to numerous advances in radical generation, allowing for milder conditions and 
convenient radical precursors (7-11).  Furthermore, photoredox catalysis (12-14) has provided 
exciting avenues for radical generation in Minisci-type additions with precursors that include 
alcohols (15, 16), ethers (17), boronic acids (18), carboxylic acids (19), and redox-active esters 
(20, 21). However, control over absolute stereochemistry in the addition of prochiral radicals has 
proven elusive, despite many of the aforementioned protocols resulting in the formation of a 
stereocenter at the benzylic position.  
 
  
  
Fig. 1. Strategies to access enantioenriched α-heterocyclic amines. (A) Typical current 
approaches. (B) The method reported herein. Ms, methanesulfonyl; Ac, acetyl. 
 
There is an increasing drive in the pharmaceutical industry for higher degrees of three-
dimensionality in lead compounds, which necessitates asymmetric introduction of chiral centers 
(22). Realization of a catalytic enantioselective Minisci-type addition would constitute a 
powerful and efficient strategy for the enantioselective synthesis of basic heteroarenes bearing 
adjacent stereocenters. To put this prospect into context, a typical existing approach to 
enantioenriched α-pyridyl amines involves diastereoselective addition of organometallics to 
enantiopure pyridyl imines derived from Ellman’s sulfonamide auxiliary (Fig. 1A, upper 
scheme) (23). Stereospecific coupling of pyrrolidine-derived chiral boronic esters has also been 
demonstrated (24). Approaches using asymmetric catalysis are typically lengthy, involving 
asymmetric reduction of a pyridyl ketone, conversion to a leaving group and azide displacement 
(lower scheme). An alternative catalytic route could involve installation of an enamide 
functionality onto the pyridine ring, followed by asymmetric hydrogenation (25) and a recent 
strategy merged nickel catalysis and photoredox catalysis to access 3- and 4-substituted pyridines 
(26). In all cases, a functional group must first be installed on the pyridine scaffold in a 
regioselective manner, necessitating additional chemical steps. Here we disclose the direct 
addition of α-amino alkyl radicals to the 2-position of basic heteroarenes by virtue of a 
combination of asymmetric Brønsted acid catalysis and photoredox catalysis (Fig 1B). This 
catalytic approach does not require prefunctionalization of the heterocycle and allows excellent 
control of both enantioselectivity and regioselectivity. The products generated possess structural 
features highly desirable in pharmaceutical compounds: a basic heteroarene, protected primary 
amine and a defined stereocenter, all in close proximity. In addition, this work constitutes a rare 
case of non-covalent organocatalysis being applied to control enantioselectivity in a single 
electron process (27-33).  
In considering a strategy towards this goal, we surmised that Minisci chemistry should, in 
principle, be amenable to asymmetric Brønsted acid catalysis (34). The heteroarene LUMO is 
significantly lowered upon protonation and the conjugate anion of the chiral acid should remain 
associated with the pyridinium cation through electrostatic and hydrogen bonding interactions, 
providing substrate activation in a chiral environment. Encouragingly, Shang, Fu and co-workers 
recently reported that catalytic amounts of achiral or racemic Brønsted and Lewis acids can be 
used to promote Minisci additions, in place of the stoichiometric acid that is typically employed 
  
(20, 21, 35, 36). Upon careful consideration of the proposed mechanism of Minisci-type 
additions (3), we envisaged two plausible scenarios that may lead to enantioenrichment in the 
product using a chiral Brønsted acid. First, a bifunctional conjugate anion, such as a chiral 
phosphate, might engage in hydrogen bonding interactions with a suitable radical nucleophile as 
well as its pyridinium counterion (Fig 2A, I). In this manner, a well-defined ternary transition 
state for enantiodetermining radical addition may occur. Following radical addition, the next step 
would be deprotonation of the aminium ion intermediate II before typically fast single electron 
oxidation of the resulting neutral radical III. Inspiring studies from Minisci and co-workers 
suggested that the addition of stabilized nucleophilic radicals to protonated heteroarenes can be 
reversible and that in such cases the irreversible, product-determining step of the process is the 
subsequent deprotonation (37). This introduces the second scenario: that deprotonation of II 
could be product-determining and either carried out by the associated chiral phosphate or an 
external base in the chiral environment that the phosphate provides. In this case, reversible 
radical addition may result in a situation where both the relative stabilities of various 
diastereomers of II and their rates of deprotonation could play important roles in determining 
product enantioselectivity.  
 
  
  
Fig. 2. Reaction development. (A) Hypothesis for enabling enantioselective Minisci-type 
addition. (B) Initial reaction evaluation on 4-methylquinoline, structures of the catalysts 
employed in this study and X-ray structure of 3a. 
We elected to use redox-active esters (RAEs) derived from amino acids as precursors to N-
acyl α-amino alkyl radicals (Fig 2A, radical generation), the latter being prochiral, nucleophilic 
radicals which possess hydrogen bond donor functionality. It is well established that facile alkyl 
radical generation occurs from RAEs on acceptance of a single electron (38-40) and there are a 
number of recent examples of photoredox catalysts being used as electron donors for this 
purpose, including in conjunction with RAEs derived from N-acyl amino acids (20, 41, 42) and 
for Minisci-type additions (20). In line with these previous studies, we envisaged a reductive 
photoredox cycle, in which fragmentation of the RAE is induced via electron-transfer from an 
Ir(II) species generated off-cycle (for fluorescence quenching studies, see Figures S1 to S4 and 
  
accompanying text). After regeneration of Ir(III) and subsequent excitation, the catalyst should 
function as the single electron oxidant required to rearomatize the heteroarene (Fig 2A, III to 3). 
To assess whether asymmetric induction could be achieved, we selected 4-methylquinoline as 
a test substrate. Irradiation from blue LEDs in the presence of 2 mol% of photocatalyst 
[Ir(dF(CF3)ppy)2(dtbpy)]PF6 and 5 mol% chiral Brønsted acid catalyst (R)-TRIP in ethyl acetate 
enabled efficient coupling of 4-methylquinoline (2a) and the RAE derived from N-acetyl-L-
phenylalanine (1a) to give 3a in 94% yield after 14h (Fig. 2B). The enantiomeric excess of the 
product was determined to be 94% and the absolute stereochemistry of the hydrochloride salt 
was determined by x-ray crystallography. Analysis of the RAE employed in this reaction showed 
that it was racemic, indicating that the stereocenter had epimerized during either synthesis or 
purification. We evaluated a selection of N-protecting groups on the amino acid portion and 
acetyl was found to be optimal in terms of both yield and enantioselectivity (Table S1). A range 
of solvents were compatible, with dioxane found to give highest enantioselectivities, and the 
photocatalyst loading could be reduced to 1 mol% (Tables S2 & S3). Numerous N-acetyl amino 
acids are commercially available, as are both catalysts in this process, factors that contribute to 
the practicality of this procedure. Control experiments without the photocatalyst, Brønsted acid 
catalyst or visible light irradiation all gave no conversion to product (Table S4). 
Encouraged by this result, we evaluated a range of amino acid-derived RAEs (Fig. 3A) and 
found the scope to be broad. Non-aromatic amino acids reacted with comparably high 
enantioselectivity; for example, the redox-active ester derived from N-Ac-Alanine gave 94% ee 
(3b). Branching in the alkyl chain was well tolerated, as observed in the RAE derived from N-
Ac-Valine (3c, 97% ee). The catalyst overrode influence from an adjacent stereocenter, as 
demonstrated in the application of each enantiomer of TRIP to the RAE derived from N-Ac-
Isoleucine (3d and 3e, both >20:1 dr). Remote arenes, esters and protected amines were well 
tolerated (3f, 3g and 3h), as was the sulfide of methionine (3i). The carbon-iodine bond of 
iodotyrosine (3j) was untouched under the mild conditions, as was the electron-rich indole 
heterocycle in tryptophan (3k).  O-Ac-Tyrosine was also appended effectively (3l).  
Although most of the RAEs used in Fig 3 were derived from enantiopure amino acids, almost 
all exhibited negligible optical rotation which we attribute to ready epimerization of the RAEs 
during synthesis or purification. The main exception to this was the RAE derived from valine, 
which appeared to be configurationally stable: the RAEs derived from L- and D- valine exhibited 
equal but opposite values of specific rotation and chiral HPLC analysis corroborated this 
observation. Control experiments with several substrates using (R)-TRIP showed that both RAEs 
gave the same enantiomer of product with the same enantiomeric excess, demonstrating that the 
stereochemistry of the RAE does not influence the stereochemical outcome (Tables S5 & S6).  
We next evaluated the scope of compatible quinolines (Fig. 3B). For unsubstituted quinoline, we 
anticipated that mixtures of regioisomers may arise as a result of competitive C2- and C4-
addition. However, we were pleased to discover that under our conditions very high (>20:1) 
regioselectivity for the C2 position was obtained, together with excellent enantioselectivity (3m, 
96% ee). Methoxy (3n), chloride (3o) and fluoride (3p) substituents were tolerated on the benzo 
portion and in all cases excellent regioselectivity was observed for addition at the C2 position. 
Regioselectivity in Minisci-type additions is known to be dependent on a range of factors, 
including solvent, acid and the nature of the radical (37, 43). In our case, use of a polar solvent 
(N,N-dimethylacetamide) resulted in a switch to moderate C4 selectivity, in line with previous 
studies (20, 37). Interestingly, use of acetyl as the N-protecting group on the RAE and TRIP as 
  
catalyst were both found to be crucial to achieving the very high observed regioselectivity for C2 
addition; variation of either resulted in only moderate C2 selectivity (Tables S9 and S10). 
Substitution was well tolerated on the pyridine portion of the quinoline and can encompass 4-
phenyl (3q), 3-methyl (3r) and a fused benzene ring (3s). An aryloxy group could be included in 
the 4-position, which is particularly relevant in agrochemicals as diaryloxy compounds 
encompass a privileged family of herbicides (3t) (44). In contrast to the excellent 
enantioselectivity obtained with quinoline, isoquinoline gave significantly lower 
enantioselectivity (Scheme S1). 
The scope was then explored on pyridines (Fig. 3C). These proved to be very amenable to 
our method and we observed the following: first, an electron-withdrawing substituent is typically 
necessary to enable productive radical addition and second, the highest enantioselectivities could 
be obtained by using the bulkier TCYP phosphoric acid (Fig. 2B, Tables S7 & S8) (45). No 
addition at the C4 position was observed in any case. The substrate could feature ester (3u, 3v, 
3x), ketone (3w), nitrile (3y) and trifluoromethyl (3z) groups at the 3- or 4- positions, together 
with other substituents around the ring, including methyls (3u, 3x, 3y), an unprotected amine 
(3za) and a bromide (3zb).  
Minisci-type additions are one of the most valuable tools for late-stage functionalization of 
pharmaceuticals and we showed that our enantioselective addition works very effectively on two 
examples (Fig. 3D) (46). Metyrapone, an inhibitor of cortisol biosynthesis, was functionalized in 
a chemo-, regio- and enantioselective manner with excellent enantiomeric excess (3zc). 
Etofibrate, a combination of Clofibrate and niacin (3zd) also underwent highly selective 
functionalization at the pyridine ring. 
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Fig. 3. Exploration of substrate scope. All yields are isolated yields, enantiomeric excesses 
determined by HPLC. Absolute stereochemistry of products assigned in analogy with 3a. (A) 
Evaluation of scope of redox active ester component. *O-Acetyl group was cleaved on 
purification. †2 mol% photocatalyst and 10 mol% chiral Brønsted acid used. (B) Scope of 
  
quinoline component. (C) Scope of compatible pyridines. (D) Application to enantioselective 
late-stage functionalization of pharmaceuticals. 
 In order to provide some mechanistic insight, we performed some preliminary 
experiments. First, the redox-active ester derived from L-proline, which does not bear a 
hydrogen bond donor, delivered product 3ze in good yield but negligible enantioselectivity (Fig. 
4A). This result supports the crucial role of attractive non-covalent interactions between the 
phosphate and either the radical nucleophile or a reaction intermediate such as II (Fig 2A). 
Second, we carried out a competition experiment between quinoline and quinoline-d7 which 
demonstrated a primary kinetic isotope effect of 3.6. This outcome suggests that the second 
mechanistic scenario is most likely in operation: a potentially complex situation wherein radical 
addition may be reversible and the relative energies of diastereomeric intermediates II and the 
rates of their deprotonation could both contribute to the excellent observed enantioselectivities 
(Fig. 4B) (37). Finally, we observed a non-linear relationship between the enantiopurity of 
catalyst and product, which suggests that two molecules of chiral phosphate may be involved in 
the deprotonation step (Figure S5). 
 
 
 
Fig. 4. Preliminary experiments to probe mechanism. (A) Outcome of reaction of a RAE that 
bears no hydrogen bond donors. (B) Kinetic isotope effect experiment.  
 
Given the extraordinary pace of advancement of the field of photoredox catalysis and the 
range of molecules that are susceptible to Brønsted acid activation, we envisage that our 
successful merger of these strategies to address the challenge of enantioselective Minisci 
chemistry will have broad impact in both areas. 
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